Stimulant treatment for children: A community perspective: Commentary

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 39, Issue 8, 2000, Pages 989-992

  Safer, Daniel J ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; COMORBIDITY; NOTE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RATING SCALE;

EID: 0033869896     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200008000-00012     Document Type: Note

References (47)

1. Child/adolescent behavioral and emotional problems: Implications of cross-informant correlations for situational specificity
2. Stimulant treatment for children: A community perspective
3. The adolescent outcome of hyperactive children diagnosed by research criteria
4. Predictors of persistence and remission into adolescence
5. Risk factors for maladjustment of Puerto Rican children
6. Hyperkinesis: Prevalence and treatment
7. Quebec Child Mental Health Survey: Prevalence of DSM-III-R mental health disorders
8. The agreement between behaviour checklists and structured psychiatric interviews for children
9. On diagnosing rare disorders rarely: Appropriate use of screening instruments
10. The Great Smoky Mountains Study of Youth: Functional impairment and serious emotional disturbance
11. The epidemiology of childhood hyperactivity
12. Adolescent outcome of hyperactive children treated with stimulants in childhood: A review
13. Antisocial disorders in hyperactive subjects from childhood to adulthood
14. Are stimulants overprescribed? Treatment of ADHD in four US communities
15. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder
16. Long-term outcome of hyperactive children: A review
17. Prevalence of hyperactivity and related treatments among elementary school children
18. Mental health professionals' perception of the utility of children, mothers and teachers as informants of childhood psychopathology
19. Identification of childhood psychiatric disorder by informant: Comparison of clinic and community samples
20. Types of ADHD in DSM-IV
21. Attention deficit disorder and age of onset of problem behaviors
22. Behavioral and developmental characteristics of aggressive, hyperactive and aggressive-hyperactive boys
23. Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinic-referred sample
24. Do parental concerns predict a diagnosis of attention-deficit hyperactivity disorder?
25. Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children
26. Ontario Child Health Study: Correlates of disorder
27. Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders
28. Prevalence of attention-deficit/hyperactivity disorder symptoms in 4- to 17-year old children in the general population
29. The use of methylphenidate in Michigan
30. Stimulant treatment in Maryland public schools
31. Increased methylphenidate usage for attention deficit disorder in the 1990s
32. Ontario Child Health Study: Social and school impairments in children aged 6 to 16 years
33. Diagnosing children with attention deficit disorders through a health department-public school partnership
34. Parenting practices and child disruptive behavior problems in early elementary school
35. Ontario Child Health Study: Prevalence of attention deficit disorder with hyperactivity
36. Correlates, associated impairments and patterns of service utilization of children with attention deficit disorder
37. Hyperactivity and conduct problems as risk factors for adolescent development
38. Which boys respond to stimulant medication?
39. Learning disabilities with and without attention-deficit hyperactivity disorder: Parents' and teachers' perspectives
40. ADD children: Who is referred from the schools?
41. A longitudinal analysis of selected risk factors for childhood psychopathology
42. A review of studies of drug treatment for attention deficit disorder with hyperactivity in adolescents
43. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample
44. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample
45. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder
46. Ten year prevalence trends for psychotropic medication from two health service systems
47. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder